Page results
-
This page has been written by the Department of Neuroradiology at the National Hospital for Neurology and Neurosurgery (NHNN). Our aim is to provide you with information about endovascular treatments…
-
“No one is invulnerable” – stark messages from patients and staff about the realities of coronavirus
The enormous pressure our staff are under was the focus of a powerful BBC News report about the surge in Covid-19 cases broadcast on Wednesday 6 January.
-
Introduction Fatigue is a common and invisible symptom that is not always obvious to others such as partners, family members, friends or colleagues. As a result others may not understand the…
-
UCLH has opened a new clinic for neurology patients with ‘long Covid’ at the National Hospital for Neurology and Neurosurgery (NHNN) with funding from the National Brain Appeal. The…
-
This talk is for people under the care of UCLH for cancer. At the talk, you'll get advice to help you to manage your energy and feel more in control of your day. You’ll learn: …
-
Who are we and what do we do? We are a therapies team comprising of Physiotherapists, Occupational Therapists and Speech and Language Therapists. We see people with neurological conditions who…
File results
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0244 - IT systems for digital dictation, speech recognition, outsourced transcription, video consultation and health information systems
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome